Epigallocatechin-3-gallate protects cardiomyocytes from hypoxia-reoxygenation damage via raising autophagy related 4C expression

References

• Zarndt R, Piloto S, Powell FL, et al. Cardiac responses to hypoxia and reoxygenation in Drosophila. Am J Physiol Regul Integr Comp Physiol. 2015;309(11):R1347–57.
   PubMed Web of Science ®Google Scholar
• Peng H, Abdel-Latif A. Cellular therapy for ischemic heart disease: an update. Adv Exp Med Biol. 2019;1201:195–213.
   PubMed Web of Science ®Google Scholar
• Lu L, Liu M, Sun R, et al. Myocardial infarction: symptoms and treatments. Cell Biochem Biophys. 2015;72(3):865–867.
   PubMed Web of Science ®Google Scholar
• Bellanti F. Hypoxia-inducible factor-1 in myocardial ischaemia/reperfusion injury. Acta Physiologica. 2017;221(2):93–94.
   Google Scholar
• Chen X, Li X, Zhang W, et al. Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 2018;83:256–270.
   PubMed Web of Science ®Google Scholar
• Mao S, Tian S, Luo X, et al. Overexpression of PLK1 relieved the myocardial ischemia-reperfusion injury of rats through inducing the mitophagy and regulating the p-AMPK/FUNDC1 axis. Bioengineered. 2021;12(1):2676–2687.
   PubMed Web of Science ®Google Scholar
• Kishimoto Y, Saita E, Taguchi C, et al. Associations between green tea consumption and coffee consumption and the prevalence of coronary artery disease. J Nutr Sci Vitaminol (Tokyo). 2020;66(3):237–245.
   PubMed Web of Science ®Google Scholar
• Xiang Q, Pang J, Chen Y, et al. Association of green tea consumption and coronary arterial disease risk in a Chinese population in Guangzhou. J Altern Complement Med. 2019;25(4):435–440.
   PubMed Web of Science ®Google Scholar
• Chu C, Deng J, Man Y, et al. Green tea extracts epigallocatechin-3-gallate for different treatments. Biomed Res Int. 2017;2017:5615647.
   PubMed Web of Science ®Google Scholar
• Yu NH, Pei H, Huang Y-P, et al. (-)-Epigallocatechin-3-gallate inhibits arsenic-induced inflammation and apoptosis through suppression of oxidative stress in mice. Cell Physiol Biochem. 2017;41(5):1788–1800.
   PubMedGoogle Scholar
• Eng QY, Thanikachalam PV, Ramamurthy S. Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases. J Ethnopharmacol. 2018;210:296–310.
   PubMed Web of Science ®Google Scholar
• Reddy AT, Lakshmi SP, Maruthi Prasad E, et al. Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-κB. Life Sci. 2020;258:118136.
   PubMed Web of Science ®Google Scholar
• Lv J, Feng M, Zhang L, et al. Protective effect of epigallocatechin gallate, a major constituent of green tea, against renal ischemia-reperfusion injury in rats. Int Urol Nephrol. 2015;47(8):1429–1435.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li N, Jiang L, et al. Neuroprotective effects of (-)-epigallocatechin-3-gallate against focal cerebral ischemia/reperfusion injury in rats through attenuation of inflammation. Neurochem Res. 2015;40(8):1691–1698.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu X, Fu X, et al. Protective effects of epigallocatechin gallate against ischemia reperfusion injury in rat skeletal muscle via activating Nrf2/HO-1 signaling pathway. Life Sci. 2019;239:117014.
   PubMed Web of Science ®Google Scholar
• Nan J, Nan C, Ye J, et al. EGCG protects cardiomyocytes against hypoxia-reperfusion injury through inhibition of OMA1 activation. J Cell Sci. 2019;132(2):220871.
   PubMed Web of Science ®Google Scholar
• Salameh A, Schuster R, Dähnert I, et al. Epigallocatechin gallate reduces ischemia/reperfusion injury in isolated perfused rabbit hearts. Int J Mol Sci. 2018;19(2):628-642.
   PubMed Web of Science ®Google Scholar
• Townsend PA, Scarabelli TM, Pasini E, et al. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. Faseb J. 2004;18(13):1621–1623.
   PubMedGoogle Scholar
• Qiu Z, He Y, Ming H, et al. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:8151836.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qiao B, Gao F, et al. Melatonin protects H9c2 cells against ischemia/reperfusion‑induced apoptosis and oxidative stress via activation of the Nrf2 signaling pathway. Mol Med Rep. 2018;18(3):3497–3505.
   PubMed Web of Science ®Google Scholar
• Li W, Li Y, Chu Y, et al. PLCE1 promotes myocardial ischemia-reperfusion injury in H/R H9c2 cells and I/R rats by promoting inflammation. Biosci Rep. 2019;39(7).
   Google Scholar
• Huang X, Fu C, Liu W, et al. Chemerin-induced angiogenesis and adipogenesis in 3 T3-L1 preadipocytes is mediated by lncRNA Meg3 through regulating Dickkopf-3 by sponging miR-217. Toxicol Appl Pharmacol. 2019;385:114815.
   PubMed Web of Science ®Google Scholar
• Feng J, Li H, Li J, et al. hnRNPK knockdown alleviates NLRP3 inflammasome priming by repressing FLIP expression in Raw264.7 macrophages. Redox Rep. 2020;25(1):104–111.
   PubMed Web of Science ®Google Scholar
• Zuo A, Zhao P, Zheng Y, et al. Tripterine inhibits proliferation, migration and invasion of breast cancer MDA-MB-231 cells by up-regulating microRNA-15a. Biol Chem. 2019;400:1069–1078.
   PubMed Web of Science ®Google Scholar
• Kong L, Wang X, Zhang K, et al. Gypenosides synergistically enhances the anti-tumor effect of 5-fluorouracil on colorectal cancer in vitro and in vivo: a role for oxidative stress-mediated DNA damage and p53 activation. PLoS One. 2015;10(9):e0137888.
   PubMed Web of Science ®Google Scholar
• Zhu CH, Lu F-P, He Y-N, et al. Regulation of avilamycin biosynthesis in streptomyces viridochromogenes: effects of glucose, ammonium ion, and inorganic phosphate. Appl Microbiol Biotechnol. 2007;73(5):1031–1038.
   PubMed Web of Science ®Google Scholar
• Sun H, Wang J, Que J, et al. RNA sequencing revealing the role of AMP-activated protein kinase signaling in mice myocardial ischemia reperfusion injury. Gene. 2019;703:91–101.
   PubMed Web of Science ®Google Scholar
• Sun S, Ou Y, Shi H, et al. Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study. J Int Med Res. 2020;48(3):300060520907783.
   PubMed Web of Science ®Google Scholar
• Ferrari R, Ceconi C, Curello S, et al. Myocardial damage during ischaemia and reperfusion. Eur Heart J. 1993;14(Suppl G):25–30.
   PubMedGoogle Scholar
• Jose Corbalan J, Vatner DE, Vatner SF. Myocardial apoptosis in heart disease: does the emperor have clothes? Basic Res Cardiol. 2016;111(3):31.
   PubMed Web of Science ®Google Scholar
• Liu XM, Yang ZM, Liu XK. Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model. Eur Rev Med Pharmacol Sci. 2017;21(12):2913–2918.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang D, Yu L, et al. Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury. Bioengineered. 2019;10(1):121–132.
   PubMed Web of Science ®Google Scholar
• Xuan F, Jian J. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux. Int J Mol Med. 2016;38(1):328–336.
   PubMed Web of Science ®Google Scholar
• Zeng X, Tan X. Epigallocatechin-3-gallate and zinc provide anti-apoptotic protection against hypoxia/reoxygenation injury in H9c2 rat cardiac myoblast cells. Mol Med Rep. 2015;12(2):1850–1856.
   PubMed Web of Science ®Google Scholar
• Estaquier J, Vallette F, Vayssiere JL, et al. The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012;942:157–183.
   PubMed Web of Science ®Google Scholar
• Cadenas S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg. 2018;1859(9):940–950.
   PubMed Web of Science ®Google Scholar
• Fabiani R, Ceconi C, Curello S, et al. Myocardial damage during ischaemia and reperfusion. Eur Heart J. 1993;14(suppl_G):25–30.
   Google Scholar
• Venardos KM, Kaye D. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007;14(14):1539–1549.
   PubMed Web of Science ®Google Scholar
• Guo W, Liu X, Li J, et al. Prdx1 alleviates cardiomyocyte apoptosis through ROS-activated MAPK pathway during myocardial ischemia/reperfusion injury. Int J Biol Macromol. 2018;112:608–615.
   PubMed Web of Science ®Google Scholar
• Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317.
   PubMed Web of Science ®Google Scholar
• Xue W, Wang X, Tang H, et al. Vitexin attenuates myocardial ischemia/reperfusion injury in rats by regulating mitochondrial dysfunction induced by mitochondrial dynamics imbalance. Biomed Pharmacother. 2020;124:109849.
   PubMed Web of Science ®Google Scholar
• Sun H, Ling S, Zhao D, et al. Ginsenoside re treatment attenuates myocardial hypoxia/reoxygenation injury by inhibiting HIF-1α ubiquitination. Front Pharmacol. 2020;11:532041.
   PubMed Web of Science ®Google Scholar
• Qin S, Chen M-H, Fang W, et al. Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model. Drug Des Devel Ther. 2019;13:2759–2768.
   PubMed Web of Science ®Google Scholar
• Wen ZP, Zeng W-J, Chen Y-H, et al. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux. J Exp Clin Cancer Res. 2019;38(1):298.
   PubMedGoogle Scholar
• Wu C, Wen Y, Guo X, et al. Genetic association, mRNA and protein expression analysis identify ATG4C as a susceptibility gene for Kashin-Beck disease. Osteoarthritis Cartilage. 2017;25(2):281–286.
   PubMed Web of Science ®Google Scholar
• Prasanth MI, Sivamaruthi B, Chaiyasut C, et al. A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients. 2019;11(2):474.
   PubMed Web of Science ®Google Scholar
• Li W, Zhu S, Li J, et al. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol. 2011;81(9):1152–1163.
   PubMed Web of Science ®Google Scholar
• Holczer M, Besze B, Zámbó V, et al. Epigallocatechin-3-gallate (EGCG) promotes autophagy-dependent survival via influencing the balance of mTOR-AMPK pathways upon endoplasmic reticulum stress. Oxid Med Cell Longev. 2018;2018:6721530.
   PubMed Web of Science ®Google Scholar
• Dong Y, Chen H, Gao J, et al. Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol. 2019;136:27–41.
   PubMed Web of Science ®Google Scholar
• Wang ZG, Wang Y, Huang Y, et al. bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway. Sci Rep. 2015;5:9287.
   PubMed Web of Science ®Google Scholar
• Huang Z, Liu Y, Huang X. Formononetin may protect aged hearts from ischemia/reperfusion damage by enhancing autophagic degradation. Mol Med Rep. 2018;18(6):4821–4830.
   PubMed Web of Science ®Google Scholar
• Ding HS, Yang J, Yang J, et al. Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway. Mol Biol Rep. 2021;48(5):3893–3901.
   PubMed Web of Science ®Google Scholar
• Liu D, Wu H, Li YZ, et al. Cellular FADD-like IL-1β-converting enzyme-inhibitory protein attenuates myocardial ischemia/reperfusion injury via suppressing apoptosis and autophagy simultaneously. Nutr Metab Cardiovasc Dis. 2021;31(6):1916–1928.
   PubMed Web of Science ®Google Scholar